Thanks for the well written post Harshitt.
I just watched their Q1FY24 earning call. I have been running a health tech start-up for 4 years now and very frequently come across various insightful data points and reports from tracxn.
Loved the analogy of tracxn being screener for VC firms (was my first thought too).
IMO one future growth driver for them (not mentioned much elsewhere) could be serious angel investors (individual/groups) who invest directly in startups/ sectors based on their research and insights via platfotms like traxcn (just like what we do today in secondary markets).
I feel we have already come a long way from mainboard stocks to SME stocks and AIF being mainstream for retail investors. Natural extension for this trend would be a way to invest in high quality/ high growth private companies/ start ups.
One more use case couple be to collab with data players of publicly listed companies (brokers, players like screener, moneycontrol, smallcase, etc.) to share some data tgrough APIs for comparing public listed companies with their private counterparts (e.g. Britannia vs Parle or Zomato vs Swiggy).
As their customer are generally crème de la crème and going ahead angels/VCs are going to grow much faster in next decade compared to the previous one. So TAM is only going to expand.
I genuinely feel that current funding winter and dull private market is the best time to research and accumulate such stocks.
YT link for Q1FY24 earning call: https://youtu.be/4AI0MJP8NTY?si=3C7vszLnXd1b13pT
PS: I have just joined VP and this is my first ever post/comment. So please excuse my assumptions/hypothetical scenarios.
| Subscribe To Our Free Newsletter |
